Safer NSAID Choice for AF Patients Receiving DOACs
Safer NSAID Choice for AF Patients Receiving DOACs
Source: JAMA, June 3, 2026.
TCTMD Coverage
Take-Home Message:
For AF patients requiring pain therapy while taking a DOAC, a COX-2–selective NSAID (e.g., celecoxib) may be a safer option than traditional nonselective NSAIDs, although bleeding risk remains elevated and careful monitoring is warranted.
https://www.tctmd.com/news/
